KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Inventory (2018 - 2025)

Historic Inventory for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to $6.6 million.

  • ClearPoint Neuro's Inventory fell 674.32% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year decrease of 674.32%. This contributed to the annual value of $6.9 million for FY2024, which is 1324.74% down from last year.
  • ClearPoint Neuro's Inventory amounted to $6.6 million in Q3 2025, which was down 674.32% from $6.3 million recorded in Q2 2025.
  • Over the past 5 years, ClearPoint Neuro's Inventory peaked at $9.8 million during Q1 2023, and registered a low of $3.3 million during Q1 2021.
  • In the last 5 years, ClearPoint Neuro's Inventory had a median value of $7.0 million in 2024 and averaged $7.1 million.
  • In the last 5 years, ClearPoint Neuro's Inventory soared by 8839.61% in 2022 and then plummeted by 2164.11% in 2025.
  • ClearPoint Neuro's Inventory (Quarter) stood at $4.9 million in 2021, then skyrocketed by 88.4% to $9.3 million in 2022, then dropped by 14.96% to $7.9 million in 2023, then dropped by 13.25% to $6.9 million in 2024, then dropped by 4.08% to $6.6 million in 2025.
  • Its Inventory was $6.6 million in Q3 2025, compared to $6.3 million in Q2 2025 and $6.6 million in Q1 2025.